# Apixaban or Enoxaparin After Head and Neck Cancer Surgery

> **NCT07189897** · PHASE4 · RECRUITING · sponsor: **Kiranya Arnold** · enrollment: 76 (estimated)

## Conditions studied

- Venous Thromboembolism
- Head and Neck Cancer

## Interventions

- **DRUG:** Enoxaparin
- **DRUG:** Apixaban

## Key facts

- **NCT ID:** NCT07189897
- **Lead sponsor:** Kiranya Arnold
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2025-10
- **Primary completion:** 2027-09
- **Final completion:** 2027-12
- **Target enrollment:** 76 (ESTIMATED)
- **Last updated:** 2025-10-08

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07189897

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07189897, "Apixaban or Enoxaparin After Head and Neck Cancer Surgery". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT07189897. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*